Skip to main content

Terry L. Bowlin

NIH Rank #16073
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 8014748Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2025 through FY2026Career claims are limited to the years shown.

NIH Funding · FY2026

Linked Award Amount
$669.9K
Full award amounts, FY2026
Award Records
1
Records listing this PI
Award-Linked Rank
#16,073
By linked amount among FY2026 PIs
Earliest Year Loaded
2025
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Terry L. Bowlin. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2026 award records by amount

NIH award records listing Terry L. Bowlin as a PI. Multi-PI records show the full award amount for context.

  • 5R33EY036947-02R33
    Translational studies to advance Filociclovir to IND submission for the treatment of adenoviral conjunctivitis and acute keratoconjunctivitis
    $669.9K
    award amount

Award organization

Organizations that administered FY2026 awards listing Terry L. Bowlin as a PI.

FY2026 award administered by Microbiotix, Inc (MA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2025
    First NIH Award
    Microbiotix, Inc
  2. 2025
    $500K Cumulative Funding
  3. 2026
    $1M Cumulative Funding